HIV replication is linked to cellular gene transcription and requires target cell activation. Therefore, should an activated, infected cell become transcriptionally inactive prior to cytopathic ...

Wistar scientists have labeled this new approach "NuKES ... a foundation for clinical testing of anti-HIV NuKES. "This exciting improvement in NK cell therapy gives me hope not just for its ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. No serious adverse events were tied to the British biotech’s bispecific T-cell engager in a phase 1/2 trial ...

Wistar scientists have labeled this this new approach ... a foundation for clinical testing of anti-HIV NuKES. “This exciting improvement in NK cell therapy gives me hope not just for its ...

HIV-1 is the most common type of HIV. When HIV-1 leaves infected cells, particles bud off from the surface of the infected cell and a protective viral envelope is produced from the plasma membrane.

Kinetic measurement of release of radioiodine from the labeled cells and a 51Cr release assay against HLA-matched and HLA-unmatched EBV lymphoma cells demonstrated little loss of cell activity and ...